PharmaShots | Incisive News in 3 Shots

Subscribe Now

UCLH

Axovant Reports Dosing of its First Patient in AXO-Lenti-PD study for Parkinson's Disease at NIHR- UCLH

Axovant Reports Dosing of its First Patient in AXO-Lenti-PD study for Parkinson's Disease at NIHR- UCLH

October 25, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us